PLRZ
NASDAQ
$14.09
Polyrizon Ltd (PLRZ)
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company is headquartered in Ra'anana, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$27M
Free Cash Flow Yield
-17.10%
Beta (5Y)
0.39
Price Chart
Valuation
Market Cap$27M
P/B1.47
Profitability
EBITDA-$5.91M
EPS-$2.07
Financial Health
Free Cash Flow Yield-17.10%
Growth & Risk
Beta (5Y)0.39
Sharpe Ratio1.20